Ertiprotafib Uses, Dosage, Side Effects and more
Ertiprotafib belongs to a novel class of insulin sensitizers developed for treatment of type 2 diabetes. In insulin-resistant rodent models, ertiprotafib and a close analog lowered both fasting blood glucose and insulin levels and improved glycemic excursion during an oral glucose tolerance test.
| Trade Name | Ertiprotafib |
| Generic | Ertiprotafib |
| Ertiprotafib Other Names | Ertiprotafib |
| Type | |
| Formula | C31H27BrO3S |
| Weight | Average: 559.52 Monoisotopic: 558.086429 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in diabetes mellitus type 2.
How Ertiprotafib works
The complete mechanism of action for ertiprotafib and related compounds in vivo may involve multiple independent mechanisms, including (but not necessarily limited to) PTP1b inhibition and dual PPARalpha/PPARgamma agonism.
